Acadia Pharmaceuticals Inc. (ACAD)

NASDAQ

$19.26

$+0.65

(+3.49%)

After-Hours

Acadia Pharmaceuticals Inc. (ACAD) Live Price Chart

Last updated: ⁦2026-10-14 20:16:00⁩. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.

Summary

Acadia Pharmaceuticals Inc. (ACAD) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $19.26, with a market capitalisation of $3.34B and a P/E ratio of 8.43. Over the past 52 weeks, its price has ranged from $18.39 to $30.96. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$3.34B
Open	$18.60
Day's High	$58.72
Day's Low	$0.65
Previous Close	$18.62
Volume	1.28M
Average Volume	1.86M
P/E Ratio	8.43
52-Week High	$30.96
52-Week Low	$18.39
Dividend Yield	--
Earnings Date	--

Acadia Pharmaceuticals Inc. (ACAD) After-Hours Stock Price

Acadia Pharmaceuticals Inc. (ACAD) is trading at $18.89 in after-hours trading as of 2026-10-14 19:59:53, up 1.46% ($0.27) from the regular-session close of $18.62.

After-hours trading shows how investors are pricing ACAD after the regular session closes. The current after-hours price is above the regular-session close, indicating positive after-hours sentiment.

Acadia Pharmaceuticals Inc. (ACAD) 7-Day Stock Price Change

Over the past seven days, Acadia Pharmaceuticals Inc. (ACAD) moved from $20.11 to $19.26, representing a decline of 4.22% ($0.85).

The stock traded between $18.39 and $20.45 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.

The average daily volume was 1.92 million shares, down versus the previous seven-day period, indicating lower trading activity.

ACAD 52-Week Price Position

Position in Range: 6.9%

52W Low$18.39

52W High$30.96

ACAD is currently trading at $19.26, placing it 6.9% of the way from its 52-week low of $18.39 to its 52-week high of $30.96. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Acadia Pharmaceuticals Inc. (ACAD)?

Acadia Pharmaceuticals Inc is a biopharmaceutical company focused on turning scientific promise into making a difference for underserved neurological and rare disease communities around the world. It has two franchises in neurological and rare diseases. Its neurological disease franchise is anchored by the commercial product NUPLAZID (pimavanserin), which is the first and only drug approved by the U.S. FDA for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis (PDP). Its rare disease is anchored by the commercial product DAYBUE, which is the first and only drug approved for the treatment of Rett syndrome. Its clinical-stage development efforts are focused on Alzheimer's disease psychosis, Lewy Body Dementia psychosis, and multiple other programs.

Acadia Pharmaceuticals Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	798
Exchange	NASDAQ
Company Website	https://www.acadia.com

How to Buy Acadia Pharmaceuticals Inc. (ACAD) Stock on MEXC

Eligible investors can buy real shares of Acadia Pharmaceuticals Inc. (ACAD) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for ACAD and Place Your Order

Open the RealStocks trading page and search for ACAD. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Acadia Pharmaceuticals Inc. (ACAD) stock price today?

Acadia Pharmaceuticals Inc. (ACAD) is currently trading at $ 19.26, up 3.45% ($0.64) from the previous close of $ 18.62. Intraday prices update in real time during regular trading hours.

2.Is ACAD stock going up or down today?

As of 2026-10-14 19:59:53, ACAD is trading at $ 19.26, up 3.45% ($0.64) from its previous close of $ 18.62. The stock has traded between $ 0.65 and $ 58.72 during today’s regular session. Past price movements do not guarantee future results.

3.What is ACAD pre-market price?

As of 2026-10-14 19:59:53, ACAD is trading at $ 18.74 in pre-market trading, up 0.64% ($0.12) from the previous close of $ 18.62. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is ACAD after-hours price?

As of 2026-10-14 19:59:53, ACAD is trading at $ 18.89 in after-hours trading, up 1.46% ($0.27) from the regular-session close of $ 18.62. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is ACAD stock trading now?

ACAD trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does ACAD sit relative to its 52-week high and low?

Over the past 52 weeks, ACAD has traded between a low of $ 18.39 and a high of $ 30.96. At $ 19.26, the stock is positioned 6.9% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Acadia Pharmaceuticals Inc. in?

Acadia Pharmaceuticals Inc. (ACAD) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Acadia Pharmaceuticals Inc.'s market capitalisation and where is it listed?

Acadia Pharmaceuticals Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 3.34B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is ACAD valued in terms of P/E ratio and EPS?

ACAD trades at a P/E ratio of 8.43, based on trailing-twelve-month EPS of $ 2.21. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Acadia Pharmaceuticals Inc. pay a dividend?

Acadia Pharmaceuticals Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.